Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PJP vs. RYHIX: which is better?

Bottom line

PJP vs RYHIX: the short answer

PJP (Invesco Pharmaceuticals ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 42% by weight.

But RYHIX is far broader, holding 135 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.

PJP is cheaper at 0.58% vs 1.38% — a difference of $80 a year per $10,000 invested.

Over five years, PJP returned +9.0% a year vs +5.1% for RYHIX.

Updated Nov 19, 2026

PJP vs RYHIX side by side

PJPRYHIX
TypeETFMutual fund
Fund familyInvescoGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.58%1.38%
Annual cost per $10k$58$138
10-yr cost on $10k (prospectus)$726$1,709
Max front loadNone—
12b-1 fee—0%
1-yr return+27.9%+14.4%
5-yr return (annualized)+9.0%+5.1%
10-yr return (annualized)+5.1%+7.9%
Best quarter+18.1%+18.7%
Worst quarter−14.8%−14.4%
Net assets (fund)$472.1M$19.4M
Number of holdings33135
Portfolio turnover36%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPJPRYHIXDifference
2025+27.9%+14.4%+13.5%
2024+9.7%+0.6%+9.1%
2023−2.2%+5.8%−8.1%
2022−2.0%−11.6%+9.6%
2021+14.5%+19.2%−4.8%
2020+11.2%+18.9%−7.8%
2019+4.7%+22.8%−18.1%
2018−1.7%+1.6%−3.3%
2017+15.3%+23.5%−8.2%
2016−19.3%−9.4%−9.9%

Source: Fund prospectus bar charts

Holdings overlap

10 of PJP's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingPJPRYHIX
Abbott Laboratories5.67%1.42%
AbbVie Inc.5.48%2.52%
Amgen Inc.5.33%1.56%
Johnson & Johnson5.18%2.88%
Merck & Co., Inc.5.06%2.04%
Eli Lilly and Co.5.02%3.63%
Gilead Sciences, Inc.4.53%1.39%
Pfizer Inc.4.50%1.25%
Regeneron Pharmaceuticals, Inc.3.14%0.90%
Bristol-Myers Squibb Co.2.94%1.22%

Source: SEC Form N-PORT

PJP top 10

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Merck & Co., Inc. — 5.06%
  7. Eli Lilly and Co. — 5.02%
  8. Corcept Therapeutics Inc. — 4.96%
  9. Gilead Sciences, Inc. — 4.53%
  10. Pfizer Inc. — 4.50%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between PJP and RYHIX?
PJP (Invesco Pharmaceuticals ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 42% by weight. But RYHIX is far broader, holding 135 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.
Which is cheaper, PJP or RYHIX?
PJP has the lower expense ratio (0.58%).
Should I own both PJP and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.